SPX3,769.03-14.25 -0.38%
DIA301.10-1.69 -0.56%
IXIC11,142.99-5.65 -0.05%

Adverum Biotechnologies 在 Ixoberogene Soroparvovec 2 期试验中首次给药

Adverum Biotechnologies 在 Ixoberogene Soroparvovec 2 期试验中首次给药

MT Newswires · 09/14/2022 05:57

Please log in to view news